Cervical cancer in the era of precision medicine: A perspective from developing countries
Cervical cancer (CC) constitutes about 70%–80% of squamous cell carcinoma and 10%–15% of adenocarcinoma. In about 90% of CC cases the Human papillomavirus (HPV) infection appears to be the main culprit. Other risk factors include smoking, compromised immune system, birth control pills, starting sex...
Guardado en:
Autores principales: | Naresh Poondla, Dhatri Madduru, Santosh Kumari Duppala, Suresh Velpula, Vandana Nunia, Simmi Kharb, Somenath Ghatak, Ashwani Kumar Mishra, Sugunakar Vuree, Md Kausar Neyaz, Prashanth Suravajhala |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/56984cbfd9ee4f35990dc0ae6fa62ced |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bio-vehicles of cytotoxic drugs for delivery to tumor specific targets for cancer precision therapy
por: Layla Al-mansoori, et al.
Publicado: (2021) -
Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine
por: Zi‐Hang Chen, et al.
Publicado: (2021) -
Personalized immunotherapy in cancer precision medicine
por: Kazuma Kiyotani, et al.
Publicado: (2021) -
Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program
por: Philippe A. Cassier, et al.
Publicado: (2022) -
Cáncer Orofaríngeo: Caracterización de la Mortalidad en Urbanización Valparaíso-Viña del Mar 2001 - 2010
por: Colil Muñoz,Carolina, et al.
Publicado: (2013)